RxDoctor Payments Data

Collette Omorogbe

Psychiatric/Mental Health · Baltimore, MDNPI 1922882232

Payments from drug & device makers

$2,160in general payments, 2019–2025

Across 91 payments — averaging $23.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$329
  • Teva Pharmaceuticals USA, Inc.$312
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$258
  • Lundbeck LLC$239
  • Otsuka America Pharmaceutical, Inc.$230
  • Alkermes, Inc.$157
  • plus $635 from 6 others

What the payments were for

  • Food & beverage$2,04895%
  • Education$1115%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,160 in reported general payments places this provider in the 85th percentile of 1,461 psychiatric/mental health providers in Maryland.

See all psychiatric/mental health providers in Maryland

Medicare billing

Part B allowed, 2024
$4,401
Medicare patients
22
Services billed
41

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Abilify MaintenaAripiprazole16$40,440
VraylarCariprazine Hcl16$19,366
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl18$2,236
Aripiprazole21$982
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine13$835
Quetiapine Fumarate40$728
Trazodone Hcl47$312
Clonazepam49$311
Duloxetine Hcl15$234
Escitalopram Oxalate18$224
Bupropion XlBupropion Hcl24$193
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine13$165
Oxcarbazepine11$148
Buspirone Hcl13$141
Mirtazapine17$136

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Otsuka America Pharmaceutical, Inc.Abilify Maintena$230$40,44016 claims
AbbVieVraylar$329$19,36616 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,461 psychiatric/mental health providers in Maryland.

Other psychiatric/mental health in Baltimore

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →